{"id":1376,"date":"2012-02-16T18:49:38","date_gmt":"2012-02-16T18:49:38","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=1376"},"modified":"2016-03-01T21:52:25","modified_gmt":"2016-03-01T21:52:25","slug":"drogues-question-de-traitement-et-de-demande","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/","title":{"rendered":"Drogues : Question de traitement et de demande"},"content":{"rendered":"<p>Le 5e jour d\u2019\u00e9tude sur le projet de loi C-10 au Comit\u00e9 s\u00e9natorial des affaires juridiques et constitutionnelles a aujourd\u2019hui abord\u00e9 de pr\u00e8s la question de la consommation de substances et du trafic de drogues illicites.<\/p>\n<blockquote><p>Ce qui fut marquant, c\u2019est que la majorit\u00e9 des t\u00e9moins s\u2019est exprim\u00e9e en faveur d\u2019une approche davantage ax\u00e9e sur le traitement des toxicomanes que sur leur<a href=\"https:\/\/drugpolicy.ca\/fr\/solutions-innovatrices-2\/politiques-cl%C3%A9s\/criminalisation-un-obstacle-au-sentiment-d%E2%80%99appartenance%E2%80%A8\/\" target=\"_blank\">criminalisation<\/a>.<\/p><\/blockquote>\n<h4>Une approche ax\u00e9e sur le traitement<\/h4>\n<p>Le Surintendant Eric Slinn, directeur de la sous-direction des drogues de la GRC et Barry MacKnight de l\u2019Association canadienne de chefs de police \u00e9taient d\u2019accord pour dire que les mesures r\u00e9pressives telles qu\u2019\u00e9labor\u00e9es dans le C-10 ne sont pas suffisantes pour lutter contre les crimes li\u00e9s aux drogues. Selon MacKnight, \u00ab le C-10 n\u2019est pas une panac\u00e9e; il faut une approche \u00e9quilibr\u00e9e et globale. L\u2019\u00e9l\u00e9ment traitement est essentiel \u00bb.<\/p>\n<p>MacKnight citait \u00e9galement les <a href=\"https:\/\/drugpolicy.ca\/fr\/solutions-innovatrices-2\/politiques-cl%C3%A9s\/une-approche-globale-ax%C3%A9e-sur-la-sant%C3%A9-la-soci%C3%A9t%C3%A9-et-les-droits-de-la-personne\/\" target=\"_blank\">approches de sant\u00e9<\/a> et de <a href=\"https:\/\/drugpolicy.ca\/fr\/solutions-innovatrices-2\/politiques-cl%C3%A9s\/accro%C3%AEtre-la-r%C3%A9duction-des-m%C3%A9faits\/\" target=\"_blank\">r\u00e9duction des m\u00e9faits<\/a>, tel que le projet Insite, en tant qu\u2019approches potentiellement compl\u00e9mentaires aux programmes de traitement et dont il faudrait davantage discuter.<\/p>\n<p>Rebecca Jesseman du <a href=\"http:\/\/www.ccsa.ca\/Fra\/Pages\/Home.aspx\" target=\"_blank\">Centre canadien de lutte contre l\u2019alcoolisme et les toxicomanies<\/a>s\u2019exprimait elle aussi en faveur d\u2019une meilleure allocation des ressources envers les traitements pour les utilisateurs de drogues. Jesseman, cependant, soulevait plusieurs pr\u00e9occupations quant \u00e0 l\u2019efficacit\u00e9 et aux r\u00e9sultats des programmes judiciaires de traitement des toxicomanes pr\u00e9sentement en vigueur dans plusieurs communaut\u00e9s au Canada. (Programmes servants, entre autres, d\u2019\u00e9chappatoire aux peines minimales obligatoires, un sujet dont j\u2019ai d\u00e9j\u00e0 discut\u00e9 en d\u00e9tail <a href=\"https:\/\/drugpolicy.ca\/fr\/2012\/02\/c-10-le-nunavut\/\" target=\"_blank\">ici<\/a>.)<\/p>\n<p>Elle nous rappelait, qu\u2019outre le fait que la plupart des gens ayant des d\u00e9m\u00eal\u00e9s judiciaires n\u2019auront pas acc\u00e8s \u00e0 de tels programmes\u2014femmes et autochtones tout particuli\u00e8rement\u2014les \u00ab r\u00e9sultats de ces programmes sont d\u2019ailleurs tr\u00e8s variables et ne sont pas bas\u00e9s sur des faits probants \u00bb.<\/p>\n<h4>Une demande qui perdure<\/h4>\n<p>Par contre, c\u2019est le s\u00e9nateur Joyal, en lisant \u00e0 voix haute une lettre sign\u00e9e par <a href=\"http:\/\/www.radio-canada.ca\/regions\/colombie-britannique\/2012\/02\/15\/001-marijuana-procureurs-generaux.shtml\" target=\"_blank\">quatre anciens procureurs g\u00e9n\u00e9raux de la Colombie-Britannique<\/a> r\u00e9clamant la l\u00e9galisation du cannabis, qui a su poser la question la plus pouss\u00e9e de la rencontre :<\/p>\n<blockquote>\n<figure id=\"attachment_1655\" aria-describedby=\"caption-attachment-1655\" style=\"width: 300px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1655\" src=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/02\/grass_300.jpg\" alt=\"Marijuana\" width=\"300\" height=\"200\" \/><figcaption id=\"caption-attachment-1655\" class=\"wp-caption-text\">Marijuana<\/figcaption><\/figure>\n<p>\u00ab La lutte contre la drogue s\u2019est av\u00e9r\u00e9e inefficace jusque lors, alors ne faudrait-il pas peut-\u00eatre consid\u00e9rer que s\u2019il y a des drogues, c\u2019est parce qu\u2019il y a une demande \u00bb?<\/p><\/blockquote>\n<p>Certes, la Coalition canadienne des politiques sur les drogues aurait pu en dire long sur cette question. Pourtant, <a href=\"https:\/\/drugpolicy.ca\/partners\/steering-committee\/donald-macpherson\/\" target=\"_blank\">Donald MacPherson<\/a>, le directeur de la CCPD s\u2019est fait refuser une audience aupr\u00e8s du comit\u00e9 et n\u2019y paraitra donc pas.<\/p>\n<p>Toutefois, une r\u00e9ponse partielle \u00e0 cette question est survenue plus tard en soir\u00e9e lorsque Heather Clark, la coll\u00e8gue de Mme Jesseman, offrait la pr\u00e9cision suivante : \u00ab Les recherches d\u00e9montrent que si on limite la disponibilit\u00e9 d\u2019une substance, les utilisateurs de drogues auront recours \u00e0 d\u2019autres substances \u00bb.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 5e jour d\u2019\u00e9tude sur le projet de loi C-10 au Comit\u00e9 s\u00e9natorial des affaires juridiques et constitutionnelles a aujourd\u2019hui abord\u00e9 de pr\u00e8s la question de la consommation de substances et du trafic de drogues illicites. Ce qui fut marquant, c\u2019est que la majorit\u00e9 des t\u00e9moins s\u2019est exprim\u00e9e en faveur d\u2019une approche davantage ax\u00e9e sur [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1377,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-1376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Le 5e jour d\u2019\u00e9tude sur le projet de loi C-10 au Comit\u00e9 s\u00e9natorial des affaires juridiques et constitutionnelles a aujourd\u2019hui abord\u00e9 de pr\u00e8s la question de la consommation de substances et du trafic de drogues illicites. Ce qui fut marquant, c\u2019est que la majorit\u00e9 des t\u00e9moins s\u2019est exprim\u00e9e en faveur d\u2019une approche davantage ax\u00e9e sur [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2012-02-16T18:49:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-01T21:52:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Drogues : Question de traitement et de demande\",\"datePublished\":\"2012-02-16T18:49:38+00:00\",\"dateModified\":\"2016-03-01T21:52:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/\"},\"wordCount\":525,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/drugtreatmentcourt_300.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/\",\"name\":\"Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/drugtreatmentcourt_300.jpg\",\"datePublished\":\"2012-02-16T18:49:38+00:00\",\"dateModified\":\"2016-03-01T21:52:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/drugtreatmentcourt_300.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/03\\\/drugtreatmentcourt_300.jpg\",\"width\":300,\"height\":200,\"caption\":\"Vancouver BC Drug Treatment Court\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/drogues-question-de-traitement-et-de-demande\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drogues : Question de traitement et de demande\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/","og_locale":"fr_FR","og_type":"article","og_title":"Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition","og_description":"Le 5e jour d\u2019\u00e9tude sur le projet de loi C-10 au Comit\u00e9 s\u00e9natorial des affaires juridiques et constitutionnelles a aujourd\u2019hui abord\u00e9 de pr\u00e8s la question de la consommation de substances et du trafic de drogues illicites. Ce qui fut marquant, c\u2019est que la majorit\u00e9 des t\u00e9moins s\u2019est exprim\u00e9e en faveur d\u2019une approche davantage ax\u00e9e sur [&hellip;]","og_url":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2012-02-16T18:49:38+00:00","article_modified_time":"2016-03-01T21:52:25+00:00","og_image":[{"width":300,"height":200,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/"},"author":{"name":"admin","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Drogues : Question de traitement et de demande","datePublished":"2012-02-16T18:49:38+00:00","dateModified":"2016-03-01T21:52:25+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/"},"wordCount":525,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/","url":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/","name":"Drogues : Question de traitement et de demande - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg","datePublished":"2012-02-16T18:49:38+00:00","dateModified":"2016-03-01T21:52:25+00:00","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/03\/drugtreatmentcourt_300.jpg","width":300,"height":200,"caption":"Vancouver BC Drug Treatment Court"},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/drogues-question-de-traitement-et-de-demande\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Drogues : Question de traitement et de demande"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/drugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=1376"}],"version-history":[{"count":0,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1376\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/1377"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=1376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=1376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=1376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}